117574-74-0

Basic information

• Product Name: Benzenemethanol, 2,5-dimethoxy-3,4,6-trimethyl-
• CAS NO: 117574-74-0
• Molecular Formula: C12H18O3
• Molecular Weight: 210.273
• Mol File: 117574-74-0.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzenemethanol, 2,5-dimethoxy-3,4,6-trimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanol, 2,5-dimethoxy-3,4,6-trimethyl-(117574-74-0)
• EPA Substance Registry System: Benzenemethanol, 2,5-dimethoxy-3,4,6-trimethyl-(117574-74-0)

Safety Data

• Hazardous Substances Data: 117574-74-0(Hazardous Substances Data)

Usage

Classification

Schedule I controlled substance (in the United States)

Derived from

Methoxy-substituted phenethylamine

Main Use

Recreational purposes for its psychedelic effects

Effects

Potent hallucinogen, mind-altering effects

Health Risks

Serious health risks and adverse effects on both mind and body

Legal Status

Classified as a Schedule I controlled substance due to high potential for abuse and lack of accepted medical use

Upstream product

• 855272-69-4 1-acetoxymethyl-2,5-dimethoxy-3,4,6-trimethyl-benzene 
• 54757-17-4 1-chloromethyl-2,5-dimethoxy-3,4,6-trimethyl-benzene 
• 700-13-0 Trimethylhydroquinone 
• 103808-42-0 2,5-dimethoxy-3,4,6-trimethylbenzaldehyde 
• 69821-05-2 1-bromo-2,5-dimethoxy-3,4,6-trimethylbenzene 
• 4537-09-1 1,4-dimethoxy-2,3,5-trimethyl-benzene 
• 7647-01-0 hydrogenchloride 
• 67-56-1 methanol 
• 89048-20-4 2,5-dimethoxy-3,4,6-trimethylbenzoic acid 
• 861356-37-8 (2,5-dimethoxy-3,4,6-trimethyl-benzylidene)-malonic acid 

Downstream Products

• 213481-70-0 1-benzyloxymethyl-2,5-dimethoxy-3,4,6-trimethylbenzene 
• 607351-63-3 2-hydroxy-5-methoxy-3,4,6-trimethylbenzaldehyde 
• 53711-21-0 2,5-dihydroxy-3,4,6-trimethyl-benzaldehyde 
• 136869-40-4 2,3,5-Trimethyl-6-(2-methyl-2-nitro-propyl)-[1,4]benzoquinone 
• 136869-43-7 2,3,5-Trimethyl-6-nitrosooxymethyl-[1,4]benzoquinone 
• 136869-42-6 2,3,5-Trimethyl-6-nitromethyl-[1,4]benzoquinone 
• 136869-41-5 2,3,5-Trimethyl-6-(2-methyl-propenyl)-[1,4]benzoquinone 
• 213481-72-2 2-benzyloxymethyl-3,5,6-trimethyl-1,4-benzoquinone 
• 213481-69-7 1-tert-Butoxymethyl-2,5-dimethoxy-3,4,6-trimethyl-benzene 
• 213481-71-1 2-(tert-butoxymethyl)-3,5,6-trimethyl-1,4-benzoquinone 
• 144707-05-1 1,4-dimethoxy-2-methoxymethyl-3,5,6-trimethylbenzene 
• 136869-44-8 2,3,5-trimethyl-6-methoxymethylbenzoquinone 
• 109885-41-8 5-(chloromethyl)-2,3,5-trimethylcyclohexa-2,5-diene-1,4-dione 
• 55758-03-7 2-hydroxymethyl-3,5,6-trimethyl-1,4-benzoquinone 

Relevant articles and documents

Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release

Histone deacetylase inhibitors (HDACi) target abnormal epigenetic states associated with a variety of pathologies, including cancer. Here, the development of a prodrug of the canonical broad-spectrum HDACi suberoylanilide hydroxamic acid (SAHA) is describ

Diels-alder trapping of ortho-quinone methides. A new entry to substituted xanthene- 1,4-diones

Highly regioselective Diels-Alder reactions of a non-protected β-hydroxy quinone have been achieved after formation of chelated lithium alkoxides. In this report, we demonstrate on a model system, that the selectivity of reactions based on 1,3-dioxy-subst

SYNTHESIS OF DIQUINONE DERIVATIVES OF DEUTEROPORPHYRIN IX FOR THE STUDY OF THE FIRST STAGE IN THE PROCESS OF PHOTOSYNTHESIS

Diquinone derivatives of deuteroporphyrin IX containing covalent bridges of different lengths between the chromophores have been synthesized.The compounds were prepared by the condensation of hydroxy-quinones with deuteroporphyrin IX using a mixed anhydri